Monopar Therapeutics(MNPR)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
MNPR is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.89.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±7.1%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 5 misses.
In plain words: it beat expectations 5 times, but the stock still fell 3 of those 5 times.
- Aug '26Beat▲ +0.4%
- May '26Beat▼ -0.7%
- Mar '26Missed▼ -0.8%
- Nov '25Missed▲ +5.4%
- Aug '25Beat▲ +14.6%
- Mar '25Missed▼ -9.7%
- Nov '24Missed▲ +7.3%
- Aug '24Missed▼ -19.6%
- May '24Beat▼ -5.2%
- Mar '24Beat▼ -7.6%
Clear beats and misses with a known reaction only. What counts as a beat
Why did MNPR fall after beating earnings?
5 of MNPR's last 10 reactions went against the EPS result. What stands out in each:
MNPR beat EPS estimates in 5 quarters, and the stock still closed lower the next day 3 times. In 2 of the 3 where we have price data, the stock had already run up before the report.
- May 14, 2026EPS beat +48.9%stock -0.7% next day
- It had risen 6.1% in the 20 trading sessions before the report, so good news may already have been priced in.
- May 9, 2024EPS beat +41.2%stock -5.2% next day
- It had risen 17.2% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 4.0% higher, but sellers took over and it closed -5.2%.
- Mar 28, 2024EPS beat +29.4%stock -7.6% next day
- It opened 4.9% lower as soon as trading resumed.
Rose despite an EPS miss (2 of 5)
- Nov 13, 2025EPS missed -20.0%stock +5.4% next day
- It had already fallen 8.7% in the 20 trading sessions before the report, so weak results may have been expected.
- Nov 8, 2024EPS missed -58.1%stock +7.3% next day
- It opened 4.3% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was MNPR's earnings move already priced in?
MNPR's move in the month before each of its last 10 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 10 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does MNPR hold its opening gap after earnings?
MNPR's opening move after each report and where it closed that day.
In 6 reports MNPR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 6 times (33%), and fully reversed 2 times. Gaps up faded 1 of 2; gaps down recovered 1 of 4.
- Aug 12, 2025ReversedOpened -1.4%, closed +14.6%
- Mar 31, 2025HeldOpened -4.0%, closed -9.7%
- Nov 8, 2024HeldOpened +4.3%, closed +7.3%
- Aug 9, 2024HeldOpened -12.7%, closed -19.6%
- May 9, 2024ReversedOpened +4.0%, closed -5.2%
- Mar 28, 2024HeldOpened -4.9%, closed -7.6%
What the history says
- It fell after 3 of its 5 EPS beats (60%): beating estimates has not been enough on its own.
MNPR earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Before open | -$0.65 | -$0.62 | +4.6% | +0.38% | -1.24% |
| May 14, 2026 | Market hours | -$0.90 | -$0.46 | +48.9% | -0.73% | -8.45% |
| Mar 27, 2026 | Market hours | -$0.51 | -$0.61 | -19.6% | -0.84% | +0.42% |
| Nov 13, 2025 | Before open | -$0.40 | -$0.48 | -20.0% | +5.36% | -7.45% |
| Aug 12, 2025 | Before open | -$0.48 | -$0.35 | +27.1% | +14.55% | +14.42% |
| May 13, 2025 | Before open | -$0.57 | -$0.38 | +33.3% | — | — |
| Mar 31, 2025 | Before open | -$0.42 | -$2.75 | -554.8% | -9.72% | -4.46% |
| Nov 8, 2024 | Before open | -$1.17 | -$1.85 | -58.1% | +7.31% | +9.66% |
| Aug 9, 2024 | Before open | -$0.47 | -$0.50 | -6.4% | -19.64% | -12.00% |
| May 9, 2024 | Before open | -$0.85 | -$0.50 | +41.2% | -5.20% | -10.00% |
| Mar 28, 2024 | Before open | -$0.85 | -$0.60 | +29.4% | -7.60% | -13.16% |
| Nov 9, 2023 | Before open | -$0.95 | -$0.70 | +26.3% | — | — |
Consensus for the next report: EPS -$0.89, revenue $0.00.
MNPR Earnings FAQ
Answers computed from Monopar Therapeutics's reported history
MNPR is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.89.
Over the last 12 quarters with a usable EPS surprise, MNPR beat the consensus estimate 7 times (58%), missed 5 and landed in line 0. It has beaten estimates in each of the last 2 counted quarters.
Across its last 10 quarters with a measured reaction, MNPR moved an average of ±7.1% in the first session after reporting. It closed higher 40% of the time; the largest gain was 14.6% and the largest drop -19.6%.
MNPR fell in the first session after 3 of its last 5 EPS beats (60%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 10 quarters with price data, MNPR moved an average of +17.0% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (5 quarters), it fell the next day 60% of the time, averaging -1.6%. After a drop of 3% or more (4 quarters), it rose the next day 50% of the time, averaging -1.8%. This describes past reports; it is not a forecast.
In 6 reports MNPR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 6 times (33%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · MNPR: 12 reported quarters, latest Aug 12, 2026. Information only, not investment advice.
Looking for more on MNPR?
Price charts, forecast, fundamentals and risk pages for MNPR are not on Tickzen yet. You can run a full stock analysis now.
Run the MNPR Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun